EPI Act 2021-04-15 Introduced in Senate Ending Pricey Insulin Act or the EPI Act

This bill establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin.

Specifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement.

This $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals.

The requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted.

]]> text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.